The treatment of tuberculosis presents an enormous challenge to global health. Tuberculosis is a leading cause of death from infectious diseases worldwide. Although several therapeutics and vaccines are available to treat and prevent tuberculosis infections, more virulent varieties of tuberculosis and increased drug resistance in the form of multi, extreme, and total drug resistant disease are major emergent threats.  It is essential that therapeutic and research strategies targeted at tuberculosis should reflect this co-evolution.